Ashburn's Quoin Pharmaceuticals Secures Up to $50 Million to Fund Its Rare Disease Pipeline Into 2029

Ashburn's Quoin Pharmaceuticals Secures Up to $50 Million to Fund Its Rare Disease Pipeline Into 2029